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The effects of Ca2+ ion on the structure of thrombin-derived and reptilase-derived fibrin gels formed at
various ionic strengths were studied turbidimetrically. For both enzymes clotting times were shorter, final
gel turbidities were higher and fibre mass/length ratios were increased as the ionic strength was lowered.
The addition of 5 mM-Ca2+ augmented each of these effects for any given ionic strength. In the thrombin
system, Ca2+ increased the final gel turbidity from 0.04 to 0.26 A6328 at ionic strength 0.15. Under identical
conditions in the reptilase system, the final gel turbidity increased from 0.03 A6328 in the absence of Ca2+
to 0.345 A32.8 in the presence of 5 mM-Ca2 . In the thrombin system, fibre mass/length ratios increased from
0.4 x 1012 to 6.9 x 1012 Da/cm in the absence of Ca2+, and from 4.4 x 1012 to 7.9 x 1012 Da/cm in the presence
of Ca2+, as the ionic strengths were decreased from 0.15 to 0.08 and to 0.11 respectively. In the reptilase
system, the mass/length ratios increased from 0.9 x 1012 to 5.8 x 1012 Da/cm in the absence of Ca2+, and
from 4.8 x 1012 to 8.7 x 1012 Da/cm in the presence of Ca2+, as the ionic strengths were decreased from 0.15
to 0.08 and to 0.10 respectively. At ionic strengths below 0.10, the presence of 5 mM-Ca2+ caused
precipitation and macroscopic aggregation of fibrinogen upon the addition of either enzyme. In the presence
of 5 mM-Ca2+, the fibres composing thrombin-induced and reptilase-induced gels were virtually identical.
INTRODUCTION
The final stages of blood coagulation involve the
thrombin-mediated cleavage of two pairs of fibrinopep-
tidase, A and B, from the a- and fl-chains of the
fibrinogen molecule (Bettelheim & Bailey, 1952; Lorand,
1952). Since fibrinopeptide A is removed at a higher rate
(Bettelheim, 1956; Blombiick & Vestermark, 1958), it
was initially postulated that fibrinopeptide A removal
was responsible for fibre lengthening, whereas fibrino-
peptide B removal resulted in lateral association and fibre
thickening (Laurent & Blomback, 1958; Laki &
Gladner, 1964). The discovery and application of
snake-venom enzymes such as reptilase, which only
removes fibrinopeptide A from fibrinogen, demonstrated
that fibrinopeptide B removal was not a prerequisite to
gel formation (Blomback et al., 1957; Laurent &
Blomback, 1958; Bilezikian et al., 1975). Although under
similar conditions reptilase-induced gels are less turbid
than thrombin-induced gels (Laurent & Blomback,
1958), gels composed of thick fibres are possible with
reptilase under conditions of low ionic strength or high
Ca2+ concentraton (Shen et al., 1977). Thus, as with
gelation, fibrinopeptide B removal, though favouring it,
is not a prerequisite for the formation of thick fibres.
The role of Ca2+, a known enhancer of clotting, in
thrombin-induced fibrin polymerization appears to be
multifaceted. Early observations of enhanced monomer
aggregation in the presence of Ca2+ (Lorand & Konishi,
1964; Boyer et al., 1972; Endres & Scheraga, 1972; Brass
et al., 1978) have been followed by the demonstration of
specific Ca2+-binding sites on the fibrinogen molecule
(Marguerie et al., 1977; Purves et al., 1978; Van
Ruijven-Vermeer et al., 1978; Nieuwenhuizen & Haver-
kate, 1983). The presence of Ca2+ on these binding sites
imparts new properties to the molecule, increasing its
heat-stability (Ly & Godal, 1973; Marguerie, 1977),
altering its degradation by plasmin (Haverkate & Timan,
1977; Lawrie & Kemp, 1978; Purves et al., 1978;
Nieuwenhuizen & Haverkate, 1983) and changing its
electron-microscopic appearance (Williams, 1981). Ca2+
at higher concentrations shortens clotting times and
enhances fibre size (Okada & Blomback, 1983a).
The present paper defines the influence offibrinopeptide
B release, in the presence and in the absence of Ca2 , on
the size of fibrin fibres formed at various ionic strengths.
The results are interpreted in the light of current kinetic
theory of fibrin polymerization (Hantgan & Hermans,
1979; Hantgan et al., 1980, 1983) and of thermodynamic
data on the impact of Ca2+ binding on fibrinogen
stability (Donovan & Mihalyi, 1985; Mihalyi &
Donovan, 1985).
EXPERIMENTAL
Human fibrinogen (grade L; A.B. Kabi, Stockholm,
Sweden) was dissolved in 0.3 M-NaCl at 25 OC. The
solution was clarified by centrifugation at 37000g for
20 min, dialysed against 0.3 M-NaCl for 24 h to remove
free Ca2+, and frozen at -70 'C. Clottability was 97%
by the method of Laki (1951). Fibrinogen concentration
was determined from absorbance at 280 nm, with an
absorption coefficient of 1.6 ml - mg-' cm-'. This fibrino-
gen preparation contained trace amounts of Factor XIII.
This contamination was considered to be acceptable
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given the minimal impact of Factor XIII on fibrin fibre
size (Carr et al., 1985).
Reptilase was purchased as Atroxin (Bothrops atrox
venom protein) from Sigma Chemical Co., dissolved in
deionized water and used without further purification. It
was maintained in an ice/water bath and used within 2 h
of being dissolved.
Purified human thrombin (2000 NIH units/ml) was
kindly provided by Dr. John Fenton, New York State
Department of Health (Fenton et al., 1977). It was
diluted with 0.3 M-NaCl to a concentration of 20 NIH
units/ml and frozen at -90 °C until use. Upon thawing,
it was maintained in an ice/water bath and used within
2 h. Gels formed by the combination of purified
fibrinogen and thrombin did not dissolve when left at
room temperature for 7 days, illustrating the virtual
absence of plasmin and plasminogen from the system.
Turbidity measurements were made at 22 °C with a
Cary 118C spectrophotometer. Gels were formed at
pH 7.4 in 0.05 M-Tris/HCl buffer. The ionic strength of
the clotting solution was adjusted by varying the amount
ofNaCl. The effects ofCa2+ were investigated by forming
gels of various ionic strengths in the presence or in the
absence of 5 mM-CaCl2 and by varying the Ca2+
concentration at a constant ionic strength (0.15). Gels
were formed directly in the cuvette by the addition of the
appropriate enzyme at time zero. Thrombin was added
to a final concentration of 1.0 NIH unit/ml, and reptilase
was added to a final concentration of 0.25 ,g/ml. The
kinetics of early turbidity increase during clotting were
measured at the HeNe laser line (632.8 nm). Turbidity
was monitored for 10 min, after which time gelation was
allowed to go to completion unobserved. After 24 h the
gels were scanned from 400 to 800 nm and the
mass/length ratios of the fibrin fibres were determined
according to the following equation (Carr & Gabriel,
1980a,b):
T = [(88/15)7r3n(dn/dc2C1t]/NA3
where T is the turbidity, n the solution refractive index,
dn/dc the refractive-index increment, A the wavelength,
C the concentration of fibrinogen in g/ml, N Avogadro's
number and It the mass/length ratio. For clear gels ,u was
determined from the slope of a plot of T versus 1/A3. For
more turbid gels, where the radius of the fibres is no
longer small relative to the incident wavelength, ,u was
obtained from the inverse of the intercept of a plot of
C/IA3 versus 1/A2 (Carr & Hermans, 1978).
RESULTS
The influence of ionic strength and Ca2+ on the
kinetics of fibrin gels formed by the action of thrombin
is illustrated in Fig. 1. Fig. 1(a) is for gels formed in the
presence of 5 mM-CaCl2, and Fig. 1(b) presents data from
gels formed in the absence of added Ca2 . In both
instances the initial rate and the final turbidity increase
with decreasing ionic strength. In this system turbidity
continued to increase for several hours. The presence of
Ca2+ augments the effect of ionic strength on initial rate
of turbidity increase and enhances the final gel turbidity.
The Ca2+-induced enhancement of gel turbidity is
greatest at higher ionic strength, 0.15, as illustrated by an
increase in final turbidity from 0.04 A6328 in the absence
of Ca2+ to 0.26 A6328 in the presence of Ca2+. This





Fig. 1. Influence of Ca2± concentration and ionic strength on the
kinetics of turbidity increase during thrombin-mediated
fibrin assembly
Turbidity was measured at 632.8 nm with time zero being
the moment of thrombin (1 unit/ml) addition. Gels in (a)
were formed in the presence of 5 mM-CaCl2, whereas those
in (b) were formed in the absence of added Ca2+. The ionic
strength is indicated at the far right in each panel. Other
clotting conditions include: pH 7.4, 0.05 M-Tris/HCl and
1 mg of fibrinogen/ml.
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Fig. 2. Effects of ionic strength and Ca2+ on thrombin-derived
and reptilase-derived fibrin fibre mass/length ratio, p
Data for gels induced by thrombin are plotted as circles (O
and *) and those mediated by reptilase are depicted as
squares (El and *). The 0 and El symbols are for gels
formed in the presence of 5 mM-CaCl2, and the * and-l
symbols are for gels formed in the absence of added Ca2 .
Precipitation was noted in the asterisked data points. Other
clotting conditions are the same as for Fig. 1.
The effect of ionic strength and Ca2+ on thrombin-
derived fibrin fibre mass/length ratio, I, is illustrated
in Fig. 2. In the absence of Ca2+ (M) , increases from
0.4 x 1012 to 6.9 x 1012 Da/cm as the ionic strength is
decreased from 0.15 to 0.08. In the presence of Ca2+ (0)
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Fig. 3. Influence of ionic strength and Ca2+ on the kinedcs of
reptilase-induced turbidity increase during fibrin gel
assembly
Turbidity was measured at 632.8 nm with time zero being
the moment of reptilase (0.25 g/ml) addition. Gels in (a)
were formed in the presence of 5 mM-CaCl2, and those in
(b) were formed in the absence of added Ca2+. The ionic
strength is indicated at the far right in each panel. Other
clotting conditions include: pH 7.4, 0.05 M-Tris/HCl and
1 mg of fibrinogen/ml.
the fibres are much larger for any given ionic strength.
For Ca2+-containing gels ,I increases from 4.4 x 1012 to
7.9 x 1012 Da/cm as the ionic strength is decreased from
0.15 to 0.11. Below an ionic strength of 0.11,
precipitation and macroscopic aggregate formation were
noted during clotting. This process produced inhomo-
geneous gels, preventing the measurement ofmass/length
ratios by turbidity.
The influence of ionic strength and Ca2+ on the early
kinetics of fibrin gels formed by the action of reptilase is
illustrated in Fig. 3. Fig. 3(a) is for gels formed in the
presence of 5 mM-CaCl2, and Fig. 3(b) shows data from
gels formed in the absence ofadded Ca2+. As was the case
with thrombin, in both instances the initial rate of rise
and the final turbidity increase with decreasing ionic
strength. Although the initial rise in turbidity after
addition of reptilase occurs later than with thrombin, the
turbidity plateaus sooner. At 300 s the turbidity of
reptilase-induced gels was frequently higher than that of
t-hrombin-induced gels. However, there was minimal
increase in gel turbidity after this period. Thus, for
similar conditions, the final turbidity of gels formed with
the use of thrombin was higher than that of gels formed
with the use of reptilase. As in the thrombin system, the
presence of Ca2+ augments the effect of ionic strength on
the initial rate of turbidity increase and enhances the final
gel turbidity. When 5 mM-Ca2+ was added, the final
turbidity increased from 0.03 to 0.345 A632.8 at an ionic
strength of 0.15 and from 0.43 to 0.77 A632.8 at an ionic
strength of 0.08.
The effects of ionic strength and Ca2+ on the
mass/length ratio ofreptilase-induced fibrin are illustrated
(O) in Fig. 2. In the absence of Ca2+ (U) the
mass/length ratio increases from 0.9 x 1012 to 5.8 x 1012
Da/cm as the ionic strength is decreased from 0.15 to
0.08. In the presence of Ca2+ (E1) the fibres are much
larger for any given ionic strength. For Ca2+-containing
gels,u increases from 4.8 x 1012 to 8.7 x 1012 Da/cm as the
ionic strength is decreased from 0.15 to 0.10. Below an
ionic strength of0.10, as seen with thrombin, precipitation
and macroscopic aggregate formation were noted during
clotting. This prevented the measurement of, below this
point. Comparison of ,c from thrombin-induced and
reptilase-induced gels reveals that, in the absence of
Ca2+, for any given ionic strength fibres are larger in the
thrombin system. In the presence of Ca2+ the fibres are
virtually identical in both systems.
DISCUSSION
The finding that reptilase-mediated fibrin gels are very
similar to thrombin gels is in good agreement with the
report by Shen et al. (1977). The structures of both types
of gels depend on ionic strength and Ca2 . In the
presence of millimolar concentrations of Ca2+ the gross
fibre size is virtually the same for both types of gels. This
is in agreement with the report by Shainoff & Dardik
(1983) of minimal contribution of b-b coupling to
monomer aggregation.
The apparent minimal role of fibrinopeptide B in fibrin
assembly has prompted speculation as to its physiological
purpose. Several authors have postulated that slow
fibrinopeptide B release allows removal of partially
cleaved fibrinogen from the circulation and thus serves
to prevent intravascular coagulation (Muller-Berghaus
et al., 1976; Shen et al., 1977; Dardik & Shainoff, 1980;
Gonda & Shainoff, 1982). Additionally, fibrinopeptide B
release may cause a subtle intrafibre molecular rearrange-
ment serving to strengthen molecular contacts between
the constituent polymer elements while enhancing
contact site orientation for enzymes such as Factor XIII
and plasmin. Studies consistent with this hypothesis have
already been reported (Furlan et al., 1976; Okada &
Blomback, 1983b).
Enhancement by Ca2+ of fibrin polymerizaton has
been studied from several approaches. Except for one
report of Ca2+-dependent proton release during peptide
cleavage (Marguerie et al., 1979), all studies have failed
to demonstrate an effect of Ca2+ on thrombin-induced
peptide release (Elias & Iyer, 1967; Boyer et al., 1972;
Blomback et al., 1978; Hardy et al., 1983). Fibrin-
fibrinogen dimer formation (Marguerie et al., 1979), the
ultimate size of fibrin fibres induced by thrombin and
reptilase (Okada & Blomback, 1983a) and Factor XIII
induced cross-linking are all Ca2+-dependent events
(Folk & Finlayson, 1977; Credo et al., 1978). The final
result of these Ca2+-mediated processes is a fibrin gel with




516 M. E. Carr, Jr., D. A. Gabriel and J. McDonagh
It has been shown that the enthalpy of thermal
denaturation and the denaturation temperature of the
D-domain increase, in the presence of Ca2+, during
clotting with thrombin (Donovan & Mihalyi, 1985).
Clotting with reptilase, which does not remove fibrino-
peptide B, failed to lead to increased enthalpy (Mihalyi &
Donovan, 1985). The altered thermodynamic stability
was not due to Factor XIII-induced cross-linking. The
authors concluded the changes in enthalpy were the
result of intermolecular interactions of the D nodules in
the clot, which are hindered by the presence of
fibrinopeptide B and strengthened by Ca2+ bound to the
high-affinity binding sites of fibrin.
If, as proposed by Hantgan and co-workers (Hantgan
& Hermans, 1979; Hantgan et al., 1980, 1983), the length
of the photofibril is the key to lateral association, the
impact offibrinopeptide B release and Ca2+ concentration
on fibrin assembly can be put in perspective. When
fibrinopeptide A is removed, monomer-monomer and
monomer-fibrinogen interactions are favoured and
protofibril formation begins. Although not a prerequisite
for monomer-monomer interaction, the additional
removal of fibrinopeptide B further enhances and
stabilizes these interactions, leading to more rapidly
produced and longer protofibrils. The addition of Ca2+
enhances the binding site for the newly exposed
N-terminal portion of the ,-chain (Laudano & Doolitte,
1981). This further stabilizes the protofibril and augments
its growth. At higher Ca2+ concentrations the relatively
weak electrostatic forces involved at the D-D lateral
contact sites are enhanced and lateral growth is further
augmented. Thus the eventual size of a fibre is dependent
on the interplay of forces favouring the production of
long protofibrils and forces strengthening the D-D lateral
contact site. Ca2+ is involved at all stages of the process
promoting monomer association, enhancing ,-epitope
binding, and augmenting D-D-lateral-contact-site bind-
ing. Combined with its cofactor role for Factor XIII
activity, this constellation of activities makes Ca2+ a
prime determinant of clot strength as demonstrated by
enhanced elastic modulus.
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